Post by Neovii

What a landmark moment at this year's European Hematology Association (EHA) Congress in Stockholm A major highlight for us was the presentation of a late-breaking abstract on June 13, sharing data from the GRAPPA study. The results were highly encouraging and add meaningful weight to the growing body of evidence supporting ATLG therapy in transplant conditioning and the prevention of graft-versus-host disease (GvHD). Thank you to the EHA community for the inspiring discussions and the opportunity to connect with leading minds in hematology. We look forward to what comes next. #EHA2026 #Hematology #HSCT #GvHD #GRAPPA #ATLG #Neovii #ClinicalData #MedicalCongress